Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.43 +0.13 (+10.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Selling, General & Administrative (2017 - 2026)

Updated

Chemomab Therapeutics' Selling, General & Administrative came in at $1.1 million for Q2 2026, up 12.7% from $975,000 a year earlier and up 18.8% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Chemomab Therapeutics reported Selling, General & Administrative of $3.79 million, up 4.0% year-over-year; for FY2025, it was $3.73 million, up 9.4% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 23.7% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $3.41 million in FY2024 (-51.8%), $7.08 million in FY2023 (-38.8%), $11.56 million in FY2022 (+91.5%) and $6.03 million in FY2021 (+368.4%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q2 2023.
  • Year-over-year, Selling, General & Administrative increased in six of the last eight quarters, with growth averaging 4.9%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 623.7%), and the weakest in Q2 2024 (a decline of 73.5%).
  • Business Quant data shows CMMB's Selling, General & Administrative at $925,000 (Q1 2026), $881,000 (Q4 2025) and $884,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Chemomab Therapeutics 10.28 Mn 10.28 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 925,000.00
Dec 31, 2025 881,000.00
Sep 30, 2025 884,000.00
Jun 30, 2025 975,000.00
Mar 31, 2025 994,000.00
Dec 31, 2024 802,000.00
Sep 30, 2024 874,000.00
Jun 30, 2024 840,000.00
Mar 31, 2024 896,000.00
Dec 31, 2023 751,000.00
Sep 30, 2023 990,000.00
Jun 30, 2023 3.18 Mn
Mar 31, 2023 2.16 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 2.89 Mn
Jun 30, 2022 3.34 Mn
Mar 31, 2022 2.58 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 1.40 Mn
API Access

Chemomab Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CMMB&period=max&api_key=YOUR_API_KEY